MARKSANS Share Price Target 2050

CAGR-based price projection for Marksans Pharma Limited (MARKSANS) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (33.0% CAGR)
Rs 304,026
2050 Target
Base Case (82.4% CAGR)
Rs 601,119,105
2050 Target
Bull Case (302.6% CAGR)
Rs 107,362,949,298,827,008
2050 Target

Current Market Snapshot

CMP: Rs 325.60
52W High: Rs 347.60
52W Low: Rs 176.14
1Y CAGR: 232.8%
3Y CAGR: 82.4%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 433 Rs 594 Rs 1,311
2028 Rs 576 Rs 1,084 Rs 5,279
2029 Rs 766 Rs 1,977 Rs 21,255
2030 Rs 1,018 Rs 3,606 Rs 85,581
2031 Rs 1,354 Rs 6,579 Rs 344,590
2032 Rs 1,800 Rs 12,002 Rs 1,387,481
2033 Rs 2,393 Rs 21,895 Rs 5,586,640
2034 Rs 3,182 Rs 39,943 Rs 22,494,400
2035 Rs 4,232 Rs 72,868 Rs 90,572,876
2036 Rs 5,627 Rs 132,933 Rs 364,688,368
2037 Rs 7,482 Rs 242,509 Rs 1,468,404,353
2038 Rs 9,949 Rs 442,407 Rs 5,912,476,325
2039 Rs 13,230 Rs 807,081 Rs 23,806,369,294
2040 Rs 17,592 Rs 1,472,354 Rs 95,855,473,714
2041 Rs 23,392 Rs 2,686,006 Rs 385,958,552,843
2042 Rs 31,105 Rs 4,900,065 Rs 1,554,047,971,813
2043 Rs 41,361 Rs 8,939,159 Rs 6,257,317,219,439
2044 Rs 54,999 Rs 16,307,654 Rs 25,194,858,521,005
2045 Rs 73,133 Rs 29,749,957 Rs 101,446,174,715,493
2046 Rs 97,246 Rs 54,272,668 Rs 408,469,305,585,759
2047 Rs 129,310 Rs 99,009,305 Rs 1,644,686,692,954,544
2048 Rs 171,946 Rs 180,622,086 Rs 6,622,270,709,185,102
2049 Rs 228,639 Rs 329,507,794 Rs 26,664,330,375,866,320
2050 Rs 304,026 Rs 601,119,105 Rs 107,362,949,298,827,008

Other MARKSANS Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the MARKSANS share price target for 2050?

Based on historical growth analysis, the MARKSANS share price target for 2050 ranges from Rs 304,026 (conservative) to Rs 601,119,105 (base case) to Rs 107,362,949,298,827,008 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of MARKSANS?

The current market price of MARKSANS (Marksans Pharma Limited) is Rs 325.60. The 52-week high is Rs 347.60 and 52-week low is Rs 176.14.

Is MARKSANS a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for MARKSANS price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 33.0% CAGR), Base (82.4% CAGR), and Bull (optimistic at 302.6% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.